Typically present in women in the 6th decade. They account for up to one-third of uterine sarcomas but only ~8% of all uterine cancers 10.
Most commonly patients present with abnormal PV bleeding, pelvic mass, and/or pelvic pain. Uncommonly, patients present with symptoms from local extension or metastases 10.
Leiomyosarcomas may arise either de novo 5 from uterine musculature or the connective tissue of uterine blood vessels, or in a pre-existing leiomyoma. The incidence of sarcomatous transformation in benign uterine leiomyomas is reported to be 0.1-0.8% 2.
The pattern of tumour spread is to the myometrium, pelvic blood vessels and lymphatics, contiguous pelvic structures, abdomen, and then distantly, most often to the lungs.
Histology can be similar to leiyomyosarcomas at other sites. A leiomyosarcoma is differentiated histologically from a leiyomyoma by noting the presence of infiltrative margins, nuclear atypia and increased mitotic figures.
The uterus is often massively enlarged.
- may show irregular central zones of low attenuation, suggesting extensive necrosis 8 and haemorrhage
- foci of calcification may be present but rare
Although it has been suggested that an irregular margin of a uterine leiomyoma on MRI is suggestive of sarcomatous transformation, this is not considered that specific.
Treatment and prognosis
They generally carry a poor prognosis 6.
Consider other uterine masses such as:
- other uterine sarcomas:
- endometrial carcinoma
- large uterine leiomyoma (fibroid): especially those with myxoid degeneration or myxoid sub type 9
- uterine smooth muscle tumours of uncertain malignant potential: rare
- 1. Rha SE, Byun JY, Jung SE et-al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol. 2003;181 (5): 1369-74. AJR Am J Roentgenol (full text) - Pubmed citation
- 2. Janus C, White M, Dottino P et-al. Uterine leiomyosarcoma--magnetic resonance imaging. Gynecol. Oncol. 1989;32 (1): 79-81. - Pubmed citation
- 3. Takemori M, Nishimura R, Sugimura K. Magnetic resonance imaging of uterine leiomyosarcoma. Arch. Gynecol. Obstet. 1992;251 (4): 215-8. - Pubmed citation
- 4. Pattani SJ, Kier R, Deal R et-al. MRI of uterine leiomyosarcoma. Magn Reson Imaging. 1995;13 (2): 331-3. Magn Reson Imaging (link) - Pubmed citation
- 5. Murase E, Siegelman ES, Outwater EK et-al. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics. 19 (5): 1179-97. Radiographics (full text) - Pubmed citation
- 6. Dinh TA, Oliva EA, Fuller AF et-al. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol. Oncol. 2004;92 (2): 648-52. doi:10.1016/j.ygyno.2003.10.044 - Pubmed citation
- 7. O'cearbhaill R, Hensley ML. Optimal management of uterine leiomyosarcoma. Expert Rev Anticancer Ther. 2010;10 (2): 153-69. doi:10.1586/era.09.187 - Pubmed citation
- 8 Mcleod AJ, Zornoza J, Shirkhoda A. Leiomyosarcoma: computed tomographic findings. Radiology. 1984;152 (1): 133-6. Radiology (abstract) - Pubmed citation
- 9. Brant WE, Lange EE. Essentials of Body MRI. Oxford University Press, USA. (2012) ISBN:0199738491. Read it at Google Books - Find it at Amazon
- 10. Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol. 2015;21 (1): 4-9. doi:10.5152/dir.2014.14053 - Free text at pubmed - Pubmed citation